From optimism to disillusion about commitment to transparency in the medico-industrial complex.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.BMJ (Clinical research ed.) · 2025
   Article
2. Clinical epidemiology: A daydream?European journal of epidemiology · 2017
   Article
3. Is Mandatory Prospective Trial Registration Working to Prevent Publication of Unregistered Trials and Selective Outcome Reporting? An Observational Study of Five Psychiatry Journals That Mandate Prospective Clinical Trial Registration.PloS one · 2015
   Observational
4. Tackling treatment uncertainties together: the evolution of the James Lind Initiative, 2003-2013.Journal of the Royal Society of Medicine · 2013
   Article
5. Modelling of mouse experimental colitis by global property screens: a holistic approach to assess drug effects in inflammatory bowel disease.PloS one · 2012
   Article
6. Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.Journal of the Royal Society of Medicine · 2011
   Article
7. Public health research systems in the European union.Health research policy and systems · 2011
   Article
8. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.BMJ (Clinical research ed.) · 2010
   Article
9. Managing allegations of research misconduct.Journal of the Royal Society of Medicine · 2009
   Article
10. A lesson learnt: the rise and fall of Lariam and Halfan.Journal of the Royal Society of Medicine · 2007
    Review
11. Transparency in health technology assessments.BMJ (Clinical research ed.) · 2007
    Article
12. Reasons for optimism not disillusionment.Journal of the Royal Society of Medicine · 2006
    Article
13. Better research for better healthcare.Journal of the Royal Society of Medicine · 2006
    Article

Corrections and comments

• Commented on by
  Journals join the podcast revolution.2006
• Commented on by
  Better research for better healthcare.2006
• Commented on by
  Reasons for optimism not disillusionment.2006

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as